Circulating tumor DNA: Solid data from liquid biopsies

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Lung cancer screening: No more excuses

Improving health care by embracing Systems Theory

Historical perspectives of The American Association for Thoracic Surgery: Julian Johnson (1906–1987) J. William Gaynor, MD The Journal of Thoracic and.

Intrinsic cardiac stem cells are essential for regeneration

Abracadabra I, II…HeartMate 3?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Surgeons, valve repair in severely unbalanced atrioventricular septal defect, and the emperor's new clothes David M. Overman, MD The Journal of Thoracic.

Bigger The Journal of Thoracic and Cardiovascular Surgery

The lord of the rings Antonio Miceli, MD, PhD

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Yang Zhang, MD, Haiquan Chen, MD, PhD

Support Your Specialty

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Get it right the first time

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Afshin Ehsan, MD, Thomas Ng, MD

Is endoluminal vacuum therapy “sponge worthy”?

A fate worse than death Jennifer S. Lawton, MD

Attachment disorder in thoracoabdominal surgery

Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor Verdi J. DiSesa, MD, MBA The Journal of.

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Who is your plastic surgeon

First nights, the adrenal axis, and steroids

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

Bicuspid aortopathy: Seeing the forest for the trees

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Managing conflicts of interest

Aritoshi Hattori, MD, Kenji Suzuki, MD

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

More than vital: Who bears the burden?

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

Circulating tumor DNA: Solid data from liquid biopsies David S. Schrump, MD, MBA The Journal of Thoracic and Cardiovascular Surgery Volume 154, Issue 3, Pages 1132-1133 (September 2017) DOI: 10.1016/j.jtcvs.2017.05.059 Copyright © 2017 Terms and Conditions

Figure 1 Evaluation of circulating tumor DNA: An evolving paradigm for precision cancer therapy. cfDNA, Cell-free DNA; NGS, next generation sequencing. The Journal of Thoracic and Cardiovascular Surgery 2017 154, 1132-1133DOI: (10.1016/j.jtcvs.2017.05.059) Copyright © 2017 Terms and Conditions

Evaluation of circulating tumor DNA: an evolving paradigm for precision cancer therapy. The Journal of Thoracic and Cardiovascular Surgery 2017 154, 1132-1133DOI: (10.1016/j.jtcvs.2017.05.059) Copyright © 2017 Terms and Conditions